Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 22:6:18.
doi: 10.1186/s40942-020-00221-4. eCollection 2020.

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

Carmen A Puliafito  1 , Charles C Wykoff  2
Affiliations

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

Carmen A Puliafito et al. Int J Retina Vitreous. .

Abstract

We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3) neovascular age-related macular degeneration; (4) drug delivery and devices and (5) diabetic retinopathy.

Keywords: Artificial intelligen; Diabetic retinopathy; Geographic atrophy; Imaging; Neovascular AMD.

PubMed Disclaimer

Conflict of interest statement

Competing interestsCP: none CW: Research Support: Adverum, Aerpio, Allergan, Apellis, Clearside, Genentech, Neurotech, Novartis, Ophthotech, Opthea, Regeneron, Regenxbio, Roche, Samsung, Santen. Consulting: Alimera Sciences, Adverum, Aerpio, Allegro, Allergan, Apellis, Bayer, Clearside, D.O.R.C., EyePoint, Genentech, Kodiak, Notal Vision, Novartis, ONL Therapeutics, Ophthotech, PolyPhotonix, RecensMedical, Regeneron, Regenxbio, Roche, Santen. Speakers Bureau: Regeneron.

References

    1. Puliafito CA, Wykoff CC. Looking Ahead in Retinal Disease Management: highlights of the 2019 angiogenesis, exudation and degeneration symposium. International Journal of Retina and Vitreous. 2019 May 29 (Epub ahead of print). - PMC - PubMed
    1. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol. 2001;85(3):261–266. doi: 10.1136/bjo.85.3.261. - DOI - PMC - PubMed
    1. Holekamp N, Wykoff CC, Schmitz-Valckenberg S, et al. Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective proxima A and B clinical trials. Ophthalmology. 2019 doi: 10.1016/j.ophtha.2019.12.009. - DOI - PubMed
    1. ClinicalTrials.gov Identifier: NCT03891875.
    1. ClinicalTrials.gov Identifier: NCT03626636.

LinkOut - more resources